Celldex Therapeutics, Inc. · NASDAQ:CLDX

Eventide Asset Management, LLC's stake in Celldex Therapeutics, Inc. fell to 2.00% (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Eventide Asset Management, LLC's stake in Celldex Therapeutics, Inc. fell to 2.00%, 1,356,186 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
2.00%
Shares
1,356,186
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Eventide Asset Management, LLC2.00%1,356,186
Finny Kuruvilla, M.D. Ph. D.2.00%1,356,186
Robin C. John2.00%1,356,186

Source

View original at SEC

Related